1. An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
   Yung-Chieh Chang et al, 2020, Applied Sciences CrossRef
2. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
   Bozena Dobrzycka et al, 2015, Tumor Biology CrossRef
3. Smac combined with DDP can inhibit drug resistance of ovarian cancer through regulation of Survivin expression
   Qi Chen et al, 2018, Cancer Biomarkers CrossRef
4. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions
   Onyinye Ugonabo et al, 2023, Biomolecules CrossRef
5. Signaling Pathways Involved in Kidney and Urinary Tract Physiology and Pathology
   João Lobo et al, 2020, Tissue-Specific Cell Signaling CrossRef
6. CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer
   Yong-Jian Deng et al, 2014, Clinical Cancer Research CrossRef
7. Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
   Xiao-Yun Zhao et al, 2020, Cells CrossRef
8. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity
   Ming-Hsien Chien et al, 2022, Expert Opinion on Therapeutic Targets CrossRef
9. Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment
   Alex Kiselyov et al, 2016, International Journal of Cancer CrossRef